Doximity Change in Accounts Receivable 2020-2025 | DOCS

Doximity change in accounts receivable for the twelve months ending March 31, 2025 was $-0.107B, a 394.43% decline year-over-year.

  • Doximity annual change in accounts receivable for 2025 was $-0.027B, a 781.34% decline from 2024.
  • Doximity annual change in accounts receivable for 2024 was $0.004B, a 115.22% decline from 2023.
  • Doximity annual change in accounts receivable for 2023 was $-0.026B, a 15.39% decline from 2022.

Doximity Change in Accounts Receivable 2020-2025 | DOCS

  • Doximity annual change in accounts receivable for 2025 was $-0.027B, a 781.34% decline from 2024.
  • Doximity annual change in accounts receivable for 2024 was $0.004B, a 115.22% decline from 2023.
  • Doximity annual change in accounts receivable for 2023 was $-0.026B, a 15.39% decline from 2022.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$46.4B
Hims & Hers Health (HIMS)$14.8B
Tempus AI (TEM)$9.8B
IRhythm Technologies (IRTC)$4.5B
Inspire Medical Systems (INSP)$3.7B
Hinge Health (HNGE)$3.5B
Privia Health (PRVA)$2.4B
10x Genomics (TXG)$1.7B
Phreesia (PHR)$1.6B
Enovis (ENOV)$1.5B
Azenta (AZTA)$1.5B
Schrodinger (SDGR)$1.5B
Clover Health Investments (CLOV)$1.5B
Omnicell (OMCL)$1.5B
Evolent Health (EVH)$1.2B
Claritev (CTEV)$655M
Veradigm (MDRX)$531M
Fulgent Genetics (FLGT)$523M
Standard BioTools (LAB)$505M
Butterfly Network (BFLY)$423M
Talkspace (TALK)$407M
TruBridge (TBRG)$313M
Outset Medical (OM)$285M
Nyxoah SA (NYXH)$254M
Health Catalyst (HCAT)$254M
SOPHiA GENETICS SA (SOPH)$209M
Zepp Health (ZEPP)$195M
CapsoVision (CV)$179M
KORU Medical Systems (KRMD)$160M
American Well (AMWL)$115M